Table 4.
Number (%) of resistant and susceptible isolates against different antibiotics among different phylogenetic groups
| Group |
A
|
|
B
1
|
|
|
B
2
|
|
D
|
Total (%) | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Type | UPEC | APEC | UPEC | APEC | UPEC | APEC | UPEC | APEC | ||||||||
| Number | 8 | 9 | 0 | 4 | 10 | 7 | 7 | 5 | 50 | |||||||
| Gentamicin | R | 5 | 0 | - | 1 | 7 | 0 | 5 | 0 | 18 (36) | ||||||
| S | 3 | 9 | - | 3 | 3 | 7 | 2 | 5 | 32 (64) | |||||||
| Tetracycline | R | 3 | 6 | - | 4 | 7 | 1 | 7 | 4 | 32 (64) | ||||||
| S | 5 | 3 | - | 0 | 3 | 6 | 0 | 1 | 18 (36) | |||||||
| Erythromycin | R | 8 | 9 | - | 4 | 10 | 7 | 7 | 5 | 50 (100) | ||||||
| S | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 (0) | |||||||
| Ciprofloxacin | R | 5 | 9 | - | 3 | 5 | 7 | 3 | 5 | 37 (74) | ||||||
| S | 3 | 0 | - | 1 | 5 | 0 | 4 | 0 | 13 (26) | |||||||
| Nalidixic acid | R | 7 | 9 | - | 4 | 10 | 7 | 7 | 5 | 49 (98) | ||||||
| S | 1 | 0 | - | 0 | 0 | 0 | 0 | 0 | 1 (2) | |||||||
| Cefixime | R | 3 | 1 | - | 3 | 8 | 4 | 5 | 3 | 27 (54) | ||||||
| S | 5 | 8 | - | 1 | 2 | 3 | 2 | 2 | 23 (46) | |||||||
| Cephalexin | R | 8 | 8 | - | 4 | 10 | 5 | 7 | 5 | 47 (94) | ||||||
| S | 0 | 1 | - | 0 | 0 | 2 | 0 | 0 | 3 (6) | |||||||
| Amoxicillin | R | 4 | 9 | - | 4 | 8 | 7 | 7 | 4 | 43 (86) | ||||||
| S | 4 | 0 | - | 0 | 2 | 0 | 0 | 1 | 7 (14) | |||||||
| Ampicillin | R | 4 | 8 | - | 4 | 9 | 5 | 7 | 5 | 42 (84) | ||||||
| S | 4 | 1 | - | 0 | 1 | 2 | 0 | 0 | 8 (16) | |||||||
| Penicillin | R | 8 | 9 | - | 4 | 10 | 7 | 7 | 5 | 50 (100) | ||||||
| S | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 (0) | |||||||
| MDR | 7 | 9 | - | 4 | 10 | 7 | 7 | 5 | 49 (98) | |||||||
R, resistant; S, susceptible; UPEC, urinary pathogenic E. coli; APEC, avian pathogenic strains; MDR, multiple drug resistance